The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

14 dead, 30 injured in Fujairah traffic accident
H.H. Sheikh Mohammed issues law defining Dubai Municipality's mandate
Sharjah reopens beaches to the public after tanker oil spill
8 arrested for Abu Dhabi hotel brawl; 2 more held for filming it
UAE President meets US delegation following trilateral talks with Ukraine, Russia
Abu Dhabi arrests man in AED 14 million gold jewellery fraud
Several dead and injured in Fujairah road collision
Ras Al Khaimah Ruler attends COP31 Leaders’ Summit
